.png)
All marketing authorization holders of medicine are hereby informed that NMRA would not register new products of Loratadine Dispersible Tablets and renew or issue import license for existing Loratadine Dispersible Tablets.
(Date: 22 December 2022)
National Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka